Evidence map›Paper›PMID 39076655›Full record

ReviewReviews in cardiovascular medicine2022

Novel Approaches to Program Cells to Differentiate into Cardiomyocytes in Myocardial Regeneration.

Victor Bonavida, Kaitlyn Ghassemi, Gwendolyn Ung, Keiko Inouye, Finosh G Thankam, Devendra K Agrawal

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Reviews in cardiovascular medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Victor BonavidaDepartment of Translational Research, Western University of Health Sciences, Pomona, CA 91766, USA.
Kaitlyn GhassemiDepartment of Translational Research, Western University of Health Sciences, Pomona, CA 91766, USA.
Gwendolyn UngDepartment of Translational Research, Western University of Health Sciences, Pomona, CA 91766, USA.
Keiko InouyeDepartment of Translational Research, Western University of Health Sciences, Pomona, CA 91766, USA.
Finosh G ThankamDepartment of Translational Research, Western University of Health Sciences, Pomona, CA 91766, USA.
Devendra K AgrawalDepartment of Translational Research, Western University of Health Sciences, Pomona, CA 91766, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With heart failure (HF) being one of the leading causes of hospitalization and death worldwide, multiple stem cell therapies have been attempted to accelerate the regeneration of the infarct zone. Versatile strategies have emerged to establish the cell candidates of cardiomyocyte lineage for regenerative cardiology. This article illustrates critical insights into the emerging technologies, current approaches, and translational promises on the programming of diverse cell types for cardiac regeneration.

Indexed as

cardiac regenerationcell programmingcell technologiesheart failureiPSC

Identifiers

PMID39076655
PMCPMC11270456

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.